Fairmount Funds Management LLC 13D and 13G filings for Oruka Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 7:00 pm Purchase |
2025-03-06 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 8,511,824 19.990% |
570,134 (+7.18%) |
Filing |
| 2024-11-21 6:30 pm Purchase |
2024-11-19 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,690 19.990% |
17 (+0.00%) |
Filing |
| 2024-09-13 4:57 pm Purchase |
2024-09-11 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 7,941,673 19.990% |
1,330,418 (+20.12%) |
Filing |
| 2024-09-06 5:08 pm Purchase |
2024-08-29 | 13D | Oruka Therapeutics, Inc. ORKA |
Fairmount Funds Management LLC | 6,611,255 19.990% |
6,611,255 (New Position) |
Filing |